Brought to you by 
Cerenis Therapeutics brings in €25mm with its Series A round
30 Aug 2005
Executive Summary
Cerenis Therapeutics SA (cardiovascular and metabolic drugs) has raised €25mm ($30.4mm) with its Series A venture round. Co-lead investors Sofinnova Partners and HealthCap were joined by Alta Partners, EDF Ventures, and NIF Ventures.
Deal Industry
- Biotechnology
- Pharmaceuticals
Deal Status
- Final
Deal Type
-
Financing
- Private Placement
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com